Key Focus Areas This Week: Jobs, Home Prices, Nike, McCormick, Conagra, and More
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy PHR?
Source: Barron's
Market Performance: Equities have declined for the fifth consecutive week, with the Nasdaq Composite index dropping 3.2% and the S&P 500 falling 2.1%.
Correction Status: The Nasdaq has officially entered correction territory, indicating a drop of 10% or more from its recent high.
Percentage Decline: The Nasdaq is currently down 12.6% from its record close achieved in late October.
Overall Trend: The ongoing slump reflects a broader trend of declining equity markets over the past several weeks.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PHR
Wall Street analysts forecast PHR stock price to rise
12 Analyst Rating
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 10.980
Low
24.00
Averages
29.09
High
35.00
Current: 10.980
Low
24.00
Averages
29.09
High
35.00
About PHR
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
PHREESIA Q4 ADJUSTED EBITDA REACHES USD 29.4 MILLION, BEATING IBES ESTIMATE OF USD 28.1 MILLION
Financial Comparison: PHREESIA reported a Q4 adjusted EBITDA of USD 29.4 million, indicating strong financial performance.
Industry Benchmark: In contrast, the estimate for IBESE's adjusted EBITDA stands at USD 28.1 million, highlighting a competitive landscape.
See More
PHREESIA REPORTS Q4 NET INCOME OF USD 1.295 MILLION
- Company Overview: PHR EESIA reported a net income of USD 1.295 million for Q4.
- Financial Performance: The financial results indicate a positive performance in the fourth quarter.
See More
PHREESIA REPORTS RESULTS FOR FOURTH QUARTER OF FISCAL YEAR 2026
- Fiscal Results Announcement: PHR EESIA has announced its fiscal results for the fourth quarter of 2026.
- Performance Overview: The results provide insights into the financial performance and economic standing of the organization during this period.
See More
Phreesia Set to Announce Q4 Earnings on March 30
- Earnings Announcement Schedule: Phreesia (PHR) is set to announce its Q4 earnings on March 30 after market close, with a consensus EPS estimate of $0.32, reflecting a substantial year-over-year increase of 390.9%, indicating a significant improvement in the company's profitability.
- Revenue Expectations: The anticipated revenue for Q4 is $126.63 million, representing a 15.5% year-over-year growth, which highlights the company's robust growth in the market and sustained customer demand, potentially boosting investor confidence.
- Historical Performance Review: Over the past year, Phreesia has not missed EPS estimates, achieving a 100% beat on revenue estimates, showcasing the company's strong performance in revenue generation, which may attract more investor interest.
- Estimate Revision Dynamics: In the last three months, there have been no upward revisions to EPS estimates, with two downward adjustments, while revenue estimates saw one upward revision and two downward adjustments, indicating a cautious market sentiment regarding the company's future performance, which could impact short-term stock price volatility.
See More
Phreesia Reports Q4 2026 Earnings Highlights
- Financial Performance Breakthrough: Phreesia reported Q4 2026 revenue of $127.1 million, a 16% year-over-year increase, with growth driven by Payment Solutions following the AccessOne acquisition, indicating the company's resilience in a competitive market.
- Record Free Cash Flow: The company achieved a quarterly record free cash flow of $28.5 million in Q4, reflecting significant improvements in operating cash flow primarily due to changes in working capital and contributions from AccessOne.
- Revenue Outlook Adjustment: Management lowered the fiscal 2027 revenue outlook to $510 million to $520 million from the previous range of $545 million to $559 million, primarily due to reduced spending commitments from Network Solutions clients, highlighting market uncertainty.
- Operational Leverage Maintained: Despite the revenue outlook reduction, management maintained the adjusted EBITDA guidance for fiscal 2027 at $125 million to $135 million, demonstrating the company's ability to enhance operational efficiency and cost discipline, particularly through AI-driven improvements.
See More
Phreesia Q4 Earnings Report Analysis
- Earnings Miss: Phreesia reported a Q4 GAAP EPS of $0.02, falling short of expectations by $0.04, indicating potential challenges in profitability that may affect investor confidence.
- Significant Revenue Growth: The company achieved revenue of $127.07 million, representing a 15.9% year-over-year increase and exceeding expectations by $0.44 million, suggesting strong market demand that could lay the groundwork for future growth.
- Market Reaction Analysis: Despite the revenue beat, the earnings miss may pressure the stock price in the short term, prompting investors to monitor the company's strategies for improving profitability.
- Future Outlook: With ongoing revenue growth, Phreesia may need to optimize its cost structure to enhance profitability, thereby strengthening its competitive position and attracting more investor interest.
See More
PHREESIA Q4 ADJUSTED EBITDA REACHES USD 29.4 MILLION, BEATING IBES ESTIMATE OF USD 28.1 MILLION
Financial Comparison: PHREESIA reported a Q4 adjusted EBITDA of USD 29.4 million, indicating strong financial performance.
Industry Benchmark: In contrast, the estimate for IBESE's adjusted EBITDA stands at USD 28.1 million, highlighting a competitive landscape.
See More
PHREESIA REPORTS Q4 NET INCOME OF USD 1.295 MILLION
- Company Overview: PHR EESIA reported a net income of USD 1.295 million for Q4.
- Financial Performance: The financial results indicate a positive performance in the fourth quarter.
See More
PHREESIA REPORTS RESULTS FOR FOURTH QUARTER OF FISCAL YEAR 2026
- Fiscal Results Announcement: PHR EESIA has announced its fiscal results for the fourth quarter of 2026.
- Performance Overview: The results provide insights into the financial performance and economic standing of the organization during this period.
See More
Phreesia Set to Announce Q4 Earnings on March 30
- Earnings Announcement Schedule: Phreesia (PHR) is set to announce its Q4 earnings on March 30 after market close, with a consensus EPS estimate of $0.32, reflecting a substantial year-over-year increase of 390.9%, indicating a significant improvement in the company's profitability.
- Revenue Expectations: The anticipated revenue for Q4 is $126.63 million, representing a 15.5% year-over-year growth, which highlights the company's robust growth in the market and sustained customer demand, potentially boosting investor confidence.
- Historical Performance Review: Over the past year, Phreesia has not missed EPS estimates, achieving a 100% beat on revenue estimates, showcasing the company's strong performance in revenue generation, which may attract more investor interest.
- Estimate Revision Dynamics: In the last three months, there have been no upward revisions to EPS estimates, with two downward adjustments, while revenue estimates saw one upward revision and two downward adjustments, indicating a cautious market sentiment regarding the company's future performance, which could impact short-term stock price volatility.
See More
Phreesia Reports Q4 2026 Earnings Highlights
- Financial Performance Breakthrough: Phreesia reported Q4 2026 revenue of $127.1 million, a 16% year-over-year increase, with growth driven by Payment Solutions following the AccessOne acquisition, indicating the company's resilience in a competitive market.
- Record Free Cash Flow: The company achieved a quarterly record free cash flow of $28.5 million in Q4, reflecting significant improvements in operating cash flow primarily due to changes in working capital and contributions from AccessOne.
- Revenue Outlook Adjustment: Management lowered the fiscal 2027 revenue outlook to $510 million to $520 million from the previous range of $545 million to $559 million, primarily due to reduced spending commitments from Network Solutions clients, highlighting market uncertainty.
- Operational Leverage Maintained: Despite the revenue outlook reduction, management maintained the adjusted EBITDA guidance for fiscal 2027 at $125 million to $135 million, demonstrating the company's ability to enhance operational efficiency and cost discipline, particularly through AI-driven improvements.
See More
Phreesia Q4 Earnings Report Analysis
- Earnings Miss: Phreesia reported a Q4 GAAP EPS of $0.02, falling short of expectations by $0.04, indicating potential challenges in profitability that may affect investor confidence.
- Significant Revenue Growth: The company achieved revenue of $127.07 million, representing a 15.9% year-over-year increase and exceeding expectations by $0.44 million, suggesting strong market demand that could lay the groundwork for future growth.
- Market Reaction Analysis: Despite the revenue beat, the earnings miss may pressure the stock price in the short term, prompting investors to monitor the company's strategies for improving profitability.
- Future Outlook: With ongoing revenue growth, Phreesia may need to optimize its cost structure to enhance profitability, thereby strengthening its competitive position and attracting more investor interest.
See More
